Pre-Implantation Methylation Multiple Screening (PIMS-Plus)

Product introduction

Pre-Implantation Methylation Multiple Screening (PIMS-Plus) can examine the copy number variation of chromosomes (CNV), DNA methylation information, monogenic disease and the variation of the chromosome structure with an upgraded self-developed single-cell genome methylation sequencing method, combined with artificial intelligence algorithm to screen the embryo developmental potential, select embryo for implantation, and thus promote the birth rates.

Product advantage

One screening covers multiple results

  • genome methylation detection
  • copy number variation of chromosomes (CNV) detection
  • molecular genetic testing of chromosome
  • epigenetic diseases detection
  • prediction of embryo potential development
  • monogenic disease detection

Service process

genetic counseling

identify the clinical indications

sample collection

6-8 trophoblast cell


sample transport

cold chain transport at -80°C

full range temperature monitoring

PIMS Plus detection

15 workdays

detection report

ranking of embryo for implantation